Clinical Trials Directory

Trials / Completed

CompletedNCT06282367

Bowel Preparation for Colonoscopy With Oral Lactulose

Novel Regimen for Colonoscopy Bowel Preparation With Oral Lactulose: A Prospective Comparative Study

Status
Completed
Phase
Study type
Observational
Enrollment
222 (actual)
Sponsor
Josue Aliaga · Other Government
Sex
All
Age
18 Years – 80 Years
Healthy volunteers

Summary

Background and Aims: The quality of colonoscopy is critically influenced by bowel preparation. Polyethylene glycol (PEG) is considered the gold standard regimen for bowel preparation, however due to the necessity of large volume of patient's tolerance is impaired, especially in the elderly population. Lactulose has been adopted in a few centers as a novel alternative for colonoscopy preparation. This study aimed to investigate the efficacy-safety profile of a lactulose-based bowel preparation in comparison to PEG for colonoscopy. Methods: Prospective non-blinded comparative study, developed in two tertiary centers from July 2021 to April 2023. Outpatients undergoing colonoscopy were randomly divided into 2 groups: Group 1 (111 patients): PEG and Group 2 (111 patients): Lactulose. The following clinical outcomes were assessed for each group: degree of bowel clearance using the Boston Score, colorectal polyp detection rate, adenoma detection rate, tolerability and side effects.

Conditions

Timeline

Start date
2021-07-01
Primary completion
2023-04-01
Completion
2023-04-01
First posted
2024-02-28
Last updated
2024-02-28

Locations

1 site across 1 country: Peru

Source: ClinicalTrials.gov record NCT06282367. Inclusion in this directory is not an endorsement.